Triple-negative breast cancer sequencing
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Sequencing analysis part of a phosphoproteomics in vivo study for the prediction of the treatment outcome in triple-negative breast cancer
应用场景：
创建时间：
2018-07-06
相关数据集
Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy combined with anti-EGFR antibodies [Nanostring]. Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy combined with anti-EGFR antibodies [Nanostring]
To find metastatic recurrence biomarkers of triple negative breast cancer (TNBC) treated by neoadjuvant chemotherapy and anti-EGFR antibodies (NAT), we evaluated tumor genomic, transcriptomic and immu
NIAID Data Ecosystem50
Expression profiling of TNBCs following atRA treatment [Affymetrix I]. Expression profiling of TNBCs following atRA treatment [Affymetrix I]
All-trans retinoic acid (atRA) regulates gene expression and is used to treat acute promyelocytic leukemia. Attempts to use atRA for breast cancer treatment without a stratification strategy have resu
NIAID Data Ecosystem40
Predicting Response and Survival in Chemotherapy-Treated Triple-Negative Breast Cancer. Homo sapiens
Gene expression data of pre-treatment samples of GEICAM2006-03 TNBC trial Patients were randomized to carboplatin or no carboplatin in the neoadjuvant setting Overall design: In the study presented he
NIAID Data Ecosystem30
Additional file 2 of Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer
Additional file 2. Table of the pairs of up- and down-regulated genes by Notch signaling. These pairs were used as biological constraints during the training of the k-top scoring pairs (k-TSPs) algori
Figshare2024-08-14 更新40
Response to Neoadjuvant Chemotherapy in Triple Negative Breast tumors.. Homo sapiens
In a cohort study of 7 women with primary invasive breast cancer, we obtained a tumor specimen before (biopsy) and after (tumorectomy) 4 cycles of NAC with epirubicine and cyclophosphamide, followed b
NIAID Data Ecosystem30
